Key clinical point: A short course of retinoid and benzoyl peroxide clears the sebaceous follicles, providing improved access for topically delivered gold microparticles prior to laser treatment.
Major finding: After three treatment sessions, researchers observed a 63% reduction in acne at 2 months, a 74% reduction at 6 months, and an 85% reduction at 12 months.
Study details: A multicenter European trial of 64 patients with mild to moderate acne.
Disclosures: Dr. Waibel disclosed that she has served on the advisory board for Sebacia and has received clinical trials funding from the company. She also reported having financial relationships with numerous other device and pharmaceutical companies.
Must Reads in Acne
FDA Approves Seysara for Severe Acne Vulgaris, Paratek Pharmaceuticals, Inc. news release; 2018 Oct 2
Prevalence of Acne Vulgaris Among Patients with HS, J Am Acad Dermatol; ePub 2018 Oct 1; Wertenteil, et al
Acne Successfully Treated with Laser Combination, Dermatolog Surg; ePub 2018 Jun 5; Bakus, et al